Progenics Narrows Losses More Than Expected

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX) narrowed fourth quarter losses more than expected to a penny per share from 32 cents per share a year earlier as revenue surged sending the stock price soaring 98 cents to close at $4.36.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here